RAPIDO vs LCRT vs Upfront Surgery - a Prospective Cohort Study - Trial NCT06212128
Access comprehensive clinical trial information for NCT06212128 through Pure Global AI's free database. This phase not specified trial is sponsored by Sengkang General Hospital and is currently Recruitment Completed. The study focuses on Rectal Cancer. Target enrollment is 57 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Sengkang General Hospital
Timeline & Enrollment
N/A
Jan 01, 2016
Jun 30, 2024
Primary Outcome
operative time required for primary resection of rectal tumour
Summary
Aim: We evaluated the surgical outcomes of 3 groups of patients with rectal cancers - RAPIDO
 vs standard long course radiotherapy (LCRT) vs upfront surgery to objectively determine the
 effects of TNT on TME.
 
 Methods: A review of prospectively collected data was performed for patients who have rectal
 cancer and underwent low anterior resection from January 2016 to May 2022. Data on patient
 demographics, disease staging, peri-operative details and up to 2-year follow-up outcomes
 were analysed. The surgical and oncological outcomes were compared. Patients were followed up
 until 31 May 2022.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06212128
Non-Device Trial